European Urology - Are All Alpha-Blockers Created the Same?
Wednesday, 15 March 2006
In the next decade, the number of men who will
consult for lower urinary tract symptoms (LUTS),
often in connection with benign prostatic hyperplasia
(BPH), will increase for two reasons: the population
is aging and fewer and fewer men will consider
LUTS as an inevitable mark of old age and accept this
bothersome condition without seeking treatment.
read more
|
Recovery Of Abnormal Ejaculation By Intermittent Tamsulosin Treatment
Tuesday, 28 February 2006
BERKELEY, CA (UroToday.com) - Alpha-blockade continues to be the predominant form of medical therapy for symptomatic bladder outlet obstruction due to BPH.
read more
|
Randomized Trial Of Saw Palmetto Versus Placebo Published In New England Journal Of Medicine Suggests No Benefit
Thursday, 23 February 2006
read more
|
European Urology - The Bell-Shaped Nitinol Prostatic Stent in the Treatment of Lower Urinary Tract Symptoms: Experience in 108 Patients
Friday, 17 February 2006
To assess the efficacy, safety, and durability of the bellshaped
nitinol prostatic stent in the treatment of moderate to severe
lower urinary tract symptoms caused by benign prostatic enlargement in
otherwise healthy patients.
read more
|
All Three-Way Foley Catheters Are Not Alike
Wednesday, 15 February 2006
BERKELEY, CA (UroToday.com) - Effective urinary bladder irrigation influences patient safety and clinical outcomes.
read more
|
Saw Palmetto Ineffective For Benign Prostatic Hyperplasia
Thursday, 09 February 2006
NEW YORK (Reuters Health) - Saw palmetto berry extract, an herbal supplement used by millions of men to treat benign prostatic hyperplasia, is largely ineffective for this purpose, according to the results of a double-blind, randomized placebo-controlled study reported in The New England Journal of Medicine for February 9th.
read more
|
Laparoscopic Prostatectomy for Benign Prostatic Hyperplasia ? A Six-Year Experience
Wednesday, 25 January 2006
The results demonstrate that resection of large prostatic adenomas can be performed with a laparoscopic approach.
read more
|
Holmium Laser Enucleation of the Prostate (HoLEP): The Endourologic Alternative to Open Prostatectomy
Tuesday, 24 January 2006
HoLEP represents a safe and effective treatment for patients with symptomatic large prostates.
read more
|
BXL628, A Novel Vitamin D3 Analog Arrests Prostate Growth in Patients with Benign Prostatic Hyperplasia: A Randomized Clinical Trial
Monday, 23 January 2006
BXL628 was able to arrest prostate growth within 12 weeks in men aged =50 years with prostatic volume =40ml.
read more
|
Doxazosin Wth Finasteride Effective Against BPH
Thursday, 12 January 2006
NEW YORK (Reuters Health) - Combination therapy with doxazosin and finasteride is more effective against benign prostatic hyperplasia (BPH) in men with moderate size or enlarged prostates than is either agent alone, researchers report in the January issue of the Journal of Urology.
read more
|
Two Weeks Of Finasteride Treatment Inhibits Prostate Angiogenesis
Wednesday, 21 December 2005
BERKELEY, CA (UroToday.com) - The 5α-reductase inhibitor finasteride blocks the conversion of testosterone to dihydrotestosterone and inhibits expression of androgen-regulated growth factors.
read more
|
Sildenafil Improves Urinary Symptoms In Men With Erectile Dysfunction
Tuesday, 22 November 2005
NEW YORK (Reuters Health) - Treatment with sildenafil (Viagra) can improve urinary tract symptoms in men with erectile dysfunction and benign prostatic hyperplasia (BPH), according to study findings presented here Monday at a meeting of the Sexual Medicine Society of North America.
read more
|
Early Genitourinary Infections In Men May Raise Risk Of Urinary Tract Symptoms
Monday, 14 November 2005
NEW YORK (Reuters Health) - Men who describe a history of gonorrhea or young-onset prostatitis appear to be at increased risk for lower urinary tract symptoms (LUTS) later in life, according to a report in the American Journal of Epidemiology for November 1.
read more
|
Tamsulosin And Naftopidil Equivalent Against BPH
Monday, 03 October 2005
NEW YORK (Reuters Health) - Tamsulosin and naftopidil, two alpha1-blockers with different affinities to the alpha1 adrenoceptor (AR) subtypes, are equally safe and effective for treating the symptoms of benign prostatic hyperplasia (BPH), according to a study conducted in Japan.
read more
|
First Long-Term Study Of Photoselective Vaporization Of The Prostate (PVP) Reinforces Procedure As An Effective, Long-Term Treatment Solution For BPH
Tuesday, 27 September 2005
San Jose, California, September 26, 2005 ? Laserscope (Nasdaq: LSCP), a pioneer in the
development and commercialization of minimally-invasive medical devices, including medical lasers
and advanced fiber-optic delivery devices, today announced the results of a milestone study
evaluating the long-term outcomes of men treated with photoselective vaporization of the prostate
(PVP) for benign prostatic hyperplasia (BPH) using the GreenLight™ laser system.
read more
|
Holmium Laser Enucleation "Ideal" For Urinary Retention Due To BPH
Thursday, 01 September 2005
NEW YORK (Reuters Health) - Holmium laser enucleation of the prostate (HoLEP) may be "the ideal treatment" for men with urinary retention due to benign prostatic hyperplasia (BPH), investigators report based on a retrospective study of 164 consecutive men treated by HoLEP between January 2000 and August 2004.
read more
|
Urologix Announces Agreement For The Development Of Real-Time Imaging System
Monday, 15 August 2005
MINNEAPOLIS, Aug 02, 2005 (BUSINESS WIRE) -- Urologix(R), Inc. (NASDAQ:ULGX), has entered into a co-development agreement with ProUroCare Medical, Inc. (OTCBB:PRRC.OB), and Rensselaer Polytechnic Institute to develop a real-time temperature imaging system, ProUroVision(TM), to be utilized with Urologix' Cooled ThermoTherapy(TM) treatment of benign prostatic hyperplasia (BPH) as well as potential new indications.
read more
|
Threshold Pharmaceuticals Announces Initiation Of Phase 3 Trial In Europe For The Treatment Of Benign Prostatic Hyperplasia
Tuesday, 09 August 2005
Threshold Pharmaceuticals Inc. today announced the initiation of a Phase 3 clinical trial as part of a registrational program of its investigational drug candidate TH-070 (lonidamine).
read more
|
BJUI Mini Reviews - Selecting Therapy for Maintaining Sexual Function in Patients with Benign Prostatic Hyperplasia
Monday, 01 August 2005
As QoL becomes
more of a consideration in managing BPH, the
effects of BPH treatment on sexual function
need to be included in patient management
decisions.
Login to read more...
|
BJUI Mini Reviews - Targeting Bladder Outlet Obstruction from Benign Prostatic Enlargement Via the Nitric Oxide/cGMP Pathway?
Monday, 01 August 2005
This review
considers the available knowledge about the
significance of the NO/cGMP pathway for
treating BOO and concomitant LUTS related to
BPE.
Login to read more...
|
BJUI Mini Reviews - The Vital Role of Creativity in Academic Departments
Monday, 01 August 2005
A university department with creativity
potentially improves its capacity to compete
for funding, people, reputation and,
eventually, postgraduate students.
Login to read more...
|
Authors Examine The Association Of Cigarette Smoking, Alcohol Consumption and Physical Activity With Lower Urinary Tract Symptoms
Tuesday, 19 July 2005
BERKELEY, CA (UroToday Inc.) - Lower urinary tract symptoms (LUTS) are a common and bothersome condition in older men. Despite the high prevalence of LUTS, not much is known about their causes as not all men with symptoms have an enlarged prostate.
read more
|
UK?S National Institute For Health and Clinical Excellence Approves PVP Procedure At National Health Service Hospitals
Tuesday, 19 July 2005
SAN JOSE, Calif. (July 19, 2005) -- Laserscope (Nasdaq: LSCP), a pioneer in the
development and commercialization of medical lasers and advanced fiber-optic delivery
devices, announced today that the United Kingdom?s National Institute for Health and Clinical
Excellence (NICE) has approved the Photoselective Vaporization of the Prostate (PVP)
procedure for the treatment of Benign Prostatic Hyperplasia, or BPH, at National Health Service
(NHS) hospitals in England and Wales.
read more
|
NSAID Use Linked To Acute Urinary Retention
Tuesday, 12 July 2005
NEW YORK (Reuters Health) - Regular use of NSAIDs may double the risk of acute urinary retention in men, new research suggests.
read more
|
Symptom Complexes Diverse Among Men Diagnosed with Benign Prostatic Hyperplasia
Friday, 08 July 2005
BERKELEY, CA (UroToday Inc.) - "Lower urinary tract symptoms" (LUTS) has become the preferred term used to classify the urinary symptoms of elderly men.
read more
|
Symptom Complexes Diverse Among Men Diagnosed with Benign Prostatic Hyperplasia
Tuesday, 05 July 2005
BERKELEY, CA (UroToday Inc.) - "Lower urinary tract symptoms" (LUTS) has become the preferred term used to classify the urinary symptoms of elderly men.
read more
|
Ardana Reports Successful Phase II Results with Novel BPH Therapy
Friday, 27 May 2005
LONDON (Agence de Presse Medicale for Reuters Health) - The Scotttish reproductive health company Ardana said on Thursday its long-acting gonadotrophin-releasing hormone antagonist, Teverelix, had successfully completed a phase II study in patients with benign prostatic hyperplasia.
read more
|
New Noninvasive, Handheld Ultrasound Device From Diagnostic Ultrasound Has Potential To Help Urologists Diagnose Bladder Outlet Obstruction
Monday, 16 May 2005
Diagnostic Ultrasound Corporation (HQ: Bothell, WA, USA) is pleased to announce the introduction of the world's first "2 in 1" handheld scanner for urological diagnosis: the BladderScan® BVM 6500.
read more
|
Dutch Primary Care Database Examined for Incidence of Acute Urinary Retention in the General Male Population
Wednesday, 27 April 2005
BERKELEY, CA (UroToday Inc.) - Acute urinary retention (AUR) is a condition characterized by a sudden inability to urinate. It is usually extremely painful and requires catheterization.
read more
|
Transurethral and Open Prostatectomy Have Similar Myocardial Infarction and Mortality Rates, but Different Reoperation Rates
Friday, 22 April 2005
BERKELEY, CA (UroToday Inc.) - Madersbacher and colleagues representing the Prostate Study Group of the Austrian Society of Urology performed a large retrospective review to compare the long-term reoperation rates and risks of myocardial infarction and mortality in patients undergoing transurethral resection (TURP) versus open prostatectomy (open PE).
read more
|
Review Examines International Prostate Symptom Scores in Young Asymptomatic American Men
Thursday, 21 April 2005
BERKELEY, CA (UroToday Inc.) - The International Prostate Symptom Score (IPSS) expands upon the American Urologic Association symptom score with an additional question regarding quality of life.
read more
|
Treatment with Alfuzosin 10 mg per Day Improves Existing Erectile and Ejaculatory Dysfunction in Men with LUTS
Wednesday, 20 April 2005
BERKELEY, CA (UroToday Inc.) - Van Mooselaar and colleagues from the ALF-ONE Study group assessed the effect of alfuzosin 10mg on sexual function in patients with lower urinary tract symptoms (LUTS) consistent with bladder outlet obstruction (BOO).
read more
|
Article Examines the Prevalence and Management of Lower Urinary Tract Symptoms in Men in the United Kingdom
Tuesday, 19 April 2005
BERKELEY, CA (UroToday Inc.) - There is a lack of epidemiological evidence on the incidence of lower urinary tract symptoms (LUTS) in men in the community and also a lack of evidence describing its impact and treatment over time.
read more
|
Prostate Cancer Family History Does Not Predict Benign Hyperplasia
Wednesday, 06 April 2005
NEW YORK (Reuters Health) - Family history of prostate cancer is associated with an increased risk of prostate cancer, but not benign prostatic hyperplasia (BPH), according to a report in the April 20th International Journal of Cancer.
read more
|
BJUI Mini Reviews - Recent Advances in Understanding the Biology of Diabetes-Associated Bladder Complications and Novel Therapy
Friday, 01 April 2005
Other aspects of the
severity of DM, e.g. duration, glycaemic
control and microvascular complications
resulting in damage to innervation of the
bladder, have been suggested as possible
mechanisms for incontinence
Login to read more...
|
Lower Urinary Tract Symptoms Not Due To BPH Are Prevalent and Increase with Age
Friday, 04 March 2005
BERKELEY, CA (UroToday Inc.) - Lower urinary tract symptoms (LUTS) are highly prevalent in men, especially as they age.
read more
|
Increased Incidence of Perioperative Complications During Cataract Surgery in Patients Taking Tamsulosin
Friday, 25 February 2005
BERKELEY, CA (UroToday Inc.) - The American Society of Cataract and Refractive Surgery (ASCRS) has issued an advisory warning for ophthalmologists regarding the potential risk of "intraoperative floppy iris syndrome" (IFIS) in patients taking tamsulosin at the time of cataract surgery.
read more
|
Gender Does Affect 24-Hour Urinary Diaries in Asymptomatic Adults
Wednesday, 16 February 2005
BERKELEY, CA (UroToday Inc.) - Normal 24-hour voiding habits are difficult to define. Although there is a sense of what is normal versus abnormal, little has been written regarding the 24-hour voiding habits in asymptomatic adults.
read more
|
Large Single Institution Experience With Botulinum Toxin A Injections For Voiding Dysfunction
Friday, 11 February 2005
BERKELEY, CA (UroToday Inc.) - Several different types of botulinum toxin are known, and botulinum toxin Type A (BTX-A) is used by urologists to treat patients with spinal cord injury and subsequent detrusor external sphincter dyssynergia (DESD).
read more
|
Single Stool Sample Fecal Occult Blood Screening Deemed Inaccurate
Thursday, 27 January 2005
BERKELEY, CA (UroToday Inc.) - Due to the large number of digital rectal exams performed in their clinics, many urologists routinely test stool for occult blood after completion of the exam.
read more
|
Study Finds That Doxazosin Improves Sexual Function in Men with Concomitant BPH and ED
Monday, 10 January 2005
BERKELEY, CA (UroToday Inc.) - Benign Prostatic Hyperplasia (BPH) is the most prevalent benign urologic condition in men, with the risk and severity of lower urinary tract (LUTS) symptoms increasing as men age.
read more
|
Novartis Says FDA Approves Enablex for Overactive Bladder
Thursday, 23 December 2004
CHICAGO (Reuters) - Novartis on Wednesday said the U.S. Food and Drug Administration had approved Enablex (darifenacin) to treat symptoms of urgent urinary incontinence and frequency.
read more
|
Doxazosin is a Safe and Effective Treatment for Men with LUTS Due to Benign Prostatic Obstruction
Tuesday, 21 December 2004
BERKELEY, CA (UroToday Inc.) - Drs. MacDonald, Wilt and Howe from Veterans Affairs Medical Center in Minneapolis, MN and Cornwall, UK performed a systematic review and meta-analysis of the randomized trials using doxazosin.
read more
|
Use of Non-Invasive Color Doppler Ultrasound Urodynamic Study Can Help Predict the Outcome of Alpha-Blocker Treatment for LUTS
Friday, 17 December 2004
BERKELEY, CA (UroToday Inc.) - A completely non-invasive pressure-flow urodynamic system based on the use of transperineal Doppler ultrasonography was developed by Dr. Ozawa and colleagues and described in the November 1998 edition of the Journal of Urology.
read more
|
Use of Non-Invasive Color Doppler Ultrasound Urodynamic Study Can Help Predict the Outcome of Alpha-Blocker Treatment for LUTS
Friday, 17 December 2004
BERKELEY, CA (UroToday Inc.) - A completely non-invasive pressure-flow urodynamic system based on the use of transperineal Doppler ultrasonography was developed by Dr. Ozawa and colleagues and described in the November 1998 edition of the Journal of Urology.
read more
|
Ratio of Free-to-Total PSA Found to be Significantly Different in Prostate Cancer and NIH Category IV Prostatitis
Monday, 13 December 2004
BERKELEY, CA (UroToday Inc.) - Prostate cancer, benign prostatic hyperplasia and prostatitis are well established causes of elevated prostate specific antigen (PSA).
read more
|
Holmium Laser Enucleation Versus Transurethral Resection of the Prostate: Results from a 2-Center, Prospective, Randomized Trial in Patients with Obstructive Benign Prostatic Hyperplasia
Tuesday, 07 December 2004
BERKELEY, CA (UroToday Inc.) - The TURP is considered the "gold standard" for surgical management of BPH. This is an elegant prospective randomized study of 100 consecutive patients with simple benign prostatic hyperplasia outlet obstruction.
read more
|
Randomized Trial of Holmium Laser Enucleation of the Prostate versus TURP Reveals Similar Efficacy and Outcomes
Tuesday, 23 November 2004
BERKELEY, CA (UroToday Inc.) - Benign prostatic hyperplasia (BPH) is a prevalent medical condition in men. By some estimates, approximately 30% of men will undergo a standard transurethral resection of the prostate (TURP) in their lifetimes.
read more
|
Tadalafil May Interact with Prostate Medication
Monday, 15 November 2004
NEW YORK (Reuters Health) - Tadalafil may augment the hypotensive effects of doxazosin in men with benign prostatic hyperplasia (BPH), researchers report in the November issue of the Journal of Neurology.
read more
|
Reporting Mean Voided Volumes in Addition to Voiding Frequency Improves Frequency/Volume Chart Accuracy
Thursday, 11 November 2004
BERKELEY, CA (UroToday Inc.) - The use of frequency volume charts (FVC) in the evaluation of lower urinary tract symptoms has been essential in correlating subjective patient symptoms with objective measures.
read more
|
BPH & Male LUTS 
